Letrobol 2.5 (Letrozole USP 2.5mg) is an oral aromatase inhibitor. It works by significantly decreasing estrogen production in the body. Primarily prescribed as a breast cancer treatment, it is also utilized off-label to stimulate ovulation.
Oxemia 50 is a prescription medication, specifically an oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor, manufactured by Zydus Lifesciences to treat anemia in adults with chronic kidney disease (CKD). It works by stimulating natural erythropoietin production.
| Strength | 50mg |
| Packaging Type | Strips |
| Packaging Size | 6 Tablets |
| Main Ingredients | Desidustat |